M. Treskova-Schwarzbach

Determinants of RSV epidemiology following suppression through pandemic contact restrictions

M. Jit, F. Krauer, S. Flasche, 2021, Epidemics.

Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection with the Delta (B.1.617.2) variant: second interim results of a living systematic review and meta-analysis, 1 January to 25 August 2021

O. Wichmann, J. Koch, T. Harder, 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Estimating RSV seasonality from pandemic disruptions: a modelling study

M. Jit, T. Harder, F. Krauer, 2022, medRxiv.

Post-COVID-19-associated morbidity in children, adolescents, and adults: A matched cohort study including more than 157,000 individuals with COVID-19 in Germany

L. Wieler, C. Scheidt-Nave, C. König, 2022, PLoS medicine.

Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence

O. Wichmann, J. Koch, T. Harder, 2021, BMC Medicine.

Post COVID-19 in children, adolescents, and adults: results of a matched cohort study including more than 150,000 individuals with COVID-19

L. Wieler, C. Scheidt-Nave, D. Hertle, 2021, medRxiv.

Development of a risk score to identify patients at high risk for a severe course of COVID-19

C. König, J. Walker, A. Schramm, 2023, Zeitschrift fur Gesundheitswissenschaften = Journal of public health.

Population with an increased risk of severe COVID-19 in Germany. Analyses from GEDA 2019/2020-EHIS

A. Rommel, E. von der Lippe, E. Lippe, 2021, Journal of health monitoring.